Forecast: Import of Glands and Other Organs for Organo-Therapeutic Uses to China

Based on the forecasted data, China’s import of glands and other organs for organo-therapeutic uses is expected to grow from 76.671 million USD in 2024 to 91.794 million USD in 2028. This demonstrates a consistent upward trend with an average annual growth rate, or CAGR, over the five years. There is a steady year-on-year increase of approximately 4-5% over this period, suggesting a robust demand for these organo-therapeutic products.

Future trends to watch for:

• Rising healthcare demands in China due to an aging population, potentially increasing imports.
• Advancements in biotechnology, which may introduce alternative therapeutic solutions, impacting import demands.
• Policy changes within China affecting import regulations and domestic production capabilities.